1,2,3,4-tetrahydro-1-phenylisoquinoline has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Horiguchi, Y; Ishikawa, M; Nakatani, M; Saitoh, T; Satoh, N; Shimazu, S; Taguchi, K; Yoneda, F | 1 |
| Egami, K; Fujisaki, M; Kajita, M; Nagatsu, T; Naoi, M; Niimura, K; Niwa, T; Sato, M; Ueki, M; Yoshida, M | 1 |
2 other study(ies) available for 1,2,3,4-tetrahydro-1-phenylisoquinoline and Parkinson Disease
| Article | Year |
|---|---|
Synthesis and in vitro cytotoxicity of 1,2,3,4-tetrahydroisoquinoline derivatives.
Topics: Animals; Apoptosis; Brain; Cells, Cultured; Membrane Transport Proteins; Microscopy, Fluorescence, Multiphoton; Neurotoxins; Parkinson Disease; PC12 Cells; Rats; Tetrahydroisoquinolines | 2006 |
Detection of 1-phenyl-N-methyl-1,2,3,4-tetrahydroisoquinoline and 1-phenyl-1,2,3,4-tetrahydroisoquinoline in human brain by gas chromatography-tandem mass spectrometry.
Topics: Aged; Aged, 80 and over; Brain; Female; Gas Chromatography-Mass Spectrometry; Humans; Isoquinolines; Male; Middle Aged; Parkinson Disease; Tetrahydroisoquinolines | 1995 |